Atrial fibrillation (AFib) is treated with medicines that slow a fast heartbeat, help restore a normal heart rhythm, or prevent blood clots that can cause a stroke. Common options include beta blockers, calcium channel blockers, antiarrhythmic drugs, and anticoagulants (blood thinners). The right medicine depends on your heart health, symptoms, stroke risk, and other medical conditions.
AFib happens when electrical signals in the heart's upper chambers become disorganized, causing an irregular heartbeat. Some people experience a racing heart, tiredness, or shortness of breath, while others notice few symptoms. Medication can help manage the condition and reduce important health risks, although different medicines serve different purposes.
What Are the Main Types of Atrial Fibrillation Medicines?
Doctors generally use three groups of medicines to manage atrial fibrillation. Each group addresses a different part of the condition, and some people need medicines from more than one group.
Medicines that slow the heart rate
Rate-control medicines reduce how quickly the lower chambers of the heart beat. They can help the heart work more efficiently and may improve symptoms such as palpitations, tiredness, or breathlessness. These drugs do not necessarily restore a regular rhythm.
Common rate-control medicines include beta blockers, certain calcium channel blockers, and digoxin.
Medicines that control heart rhythm
Rhythm-control medicines, also called antiarrhythmic drugs, help restore or maintain a more regular heartbeat. They may be considered when AFib causes troublesome symptoms, when rate control is insufficient, or when maintaining a normal rhythm is an important treatment goal.
Examples include flecainide, propafenone, amiodarone, dronedarone, dofetilide, and sotalol.
Medicines that prevent blood clots
Anticoagulants reduce the chance of blood clots forming and causing an ischemic stroke. They do not slow the heartbeat or correct the irregular rhythm. Instead, they address one of the most important risks associated with AFib.
According to the American Heart Association, AFib treatment may include medicines for stroke prevention, heart rate control, and heart rhythm control. The combination depends on the person's needs.
Which Medicines Slow a Fast Heartbeat in AFib?
When AFib makes the heart beat too quickly, doctors often begin by controlling its rate. This approach can reduce symptoms even when the heartbeat remains irregular.
Beta blockers: Metoprolol, bisoprolol, and atenolol
Beta blockers are frequently prescribed for atrial fibrillation. They reduce the effects of stress hormones on the heart, helping slow the heartbeat.
Common examples include:
Metoprolol: A widely used beta blocker that can help slow the heart rate during AFib. It is available in different formulations, which may have different dosing schedules.
Bisoprolol: Another commonly prescribed option for heart rate control. It may also be used in certain people who have other cardiovascular conditions.
Atenolol: A beta blocker that may be used to reduce heart rate and manage certain cardiovascular conditions.
Carvedilol: A beta blocker sometimes selected when AFib occurs alongside certain forms of heart failure.
Possible side effects include fatigue, dizziness, low blood pressure, and an excessively slow heartbeat. Some beta blockers may aggravate breathing problems in susceptible people, so doctors consider the patient's respiratory and cardiac history.
Beta blockers should not be stopped suddenly without medical advice, because abrupt withdrawal can worsen certain heart problems.
Calcium channel blockers: Diltiazem and verapamil
Diltiazem and verapamil are another important group of medicines used to slow the heart rate during AFib. They reduce the speed at which electrical signals travel from the upper chambers to the lower chambers of the heart.
These medicines may be used when beta blockers are unsuitable or as an alternative rate-control treatment.
Possible side effects include dizziness, low blood pressure, constipation, and a slow heartbeat. They are not suitable for everyone, especially people with certain types of heart failure involving reduced pumping function.
Not all calcium channel blockers work the same way. Amlodipine, for example, is commonly prescribed for blood pressure but is not used to control the ventricular rate in AFib.
Digoxin: When is it used?
Digoxin slows electrical signals passing through the heart's atrioventricular node, which helps control how quickly the lower chambers beat.
It may be considered for people who cannot tolerate certain other rate-control medicines or who need additional heart rate control. It can be particularly useful for controlling the heart rate while resting.
However, digoxin may be less effective when someone is physically active. It also has a relatively narrow safety range, meaning excessive amounts can cause harmful effects.
Doctors may monitor kidney function, blood potassium, and sometimes blood digoxin levels. Possible signs of toxicity include nausea, vomiting, confusion, visual disturbances, and unusual changes in heart rhythm.
Mayo Clinic identifies beta blockers, calcium channel blockers, and digoxin as medicines used for heart rate control in AFib. It also notes that digoxin may control the heart rate better at rest than during activity.
What Drugs Help Restore a Normal Heart Rhythm?
Rhythm-control medicines aim to restore the heart's usual rhythm or help maintain it after a treatment such as cardioversion. Cardioversion means restoring a normal rhythm using medicine or a controlled electrical treatment.
Antiarrhythmic drugs require careful selection because some can cause serious side effects or even trigger additional abnormal heart rhythms.
Flecainide and propafenone
Flecainide and propafenone work by changing how electrical signals travel through heart muscle. They may help restore or maintain a normal rhythm in selected people with AFib.
These medicines are generally avoided in people with certain structural heart diseases, including significant coronary artery disease or heart muscle damage, because they can increase the risk of dangerous rhythm disturbances.
Doctors may prescribe an additional rate-slowing medicine alongside them to reduce the risk of certain rapid heart rhythms.
In carefully selected patients, a clinician may recommend a "pill-in-the-pocket" approach. This involves taking a prescribed antiarrhythmic medicine when an AFib episode begins rather than taking it every day. It requires medical assessment, clear dosing instructions, and confirmation that the medicine can be used safely.
Amiodarone
Amiodarone is an effective antiarrhythmic medicine used to manage AFib in selected patients. It may help restore a normal rhythm or prevent recurring episodes.
It is sometimes considered when other rhythm-control drugs are unsuitable or unsuccessful, including in certain people with structural heart disease or heart failure.
Despite its effectiveness, amiodarone can cause important long-term side effects. These may involve the thyroid gland, lungs, liver, eyes, or skin. It can also interact with other medicines.
People receiving amiodarone generally need regular medical review and appropriate monitoring. Doctors weigh its potential benefits against these risks before recommending long-term treatment.
Dronedarone
Dronedarone is another medicine used to help maintain a normal rhythm in selected people with AFib.
It is not suitable for everyone. In particular, it should not be used in patients with permanent AFib or certain forms of heart failure because of serious safety concerns.
Doctors assess heart function, rhythm, other medicines, and possible drug interactions before prescribing it.
Sotalol and dofetilide
Sotalol and dofetilide may help maintain a normal rhythm by affecting the electrical activity of the heart.
Both medicines can sometimes cause a dangerous rhythm disturbance associated with prolongation of the QT interval, a measurement on an electrocardiogram (ECG).
Kidney function, electrolyte levels, ECG findings, and other medications are important when assessing their safety. Starting or adjusting certain antiarrhythmic treatments may require monitoring in a hospital.
The Cleveland Clinic explains that AFib treatment may involve medications to control heart rate, maintain heart rhythm, and reduce stroke risk, with treatment changing over time according to the patient's condition.
Which Blood Thinners Are Used for Atrial Fibrillation?
Blood thinners are an important part of AFib treatment for people at increased risk of stroke.
When the upper chambers of the heart do not contract normally, blood may collect in certain areas and form clots. A clot can travel to the brain and block blood flow, causing an ischemic stroke.
Anticoagulants reduce the blood's ability to form harmful clots. They do not literally make the blood thinner.
Direct oral anticoagulants (DOACs)
Direct oral anticoagulants are commonly preferred for eligible people with AFib because they are effective at preventing stroke and generally require less routine clotting-test monitoring than warfarin.
Frequently used options include:
Apixaban: An anticoagulant that blocks factor Xa, a protein involved in blood clotting.
Rivaroxaban: Another factor Xa inhibitor used to reduce stroke risk in eligible people with AFib.
Edoxaban: A factor Xa inhibitor that may be prescribed when appropriate for the patient's kidney function and clinical circumstances.
Dabigatran: An anticoagulant that works by blocking thrombin, another important clotting protein.
These medicines do not usually require regular INR testing, but they still require follow-up, particularly to assess kidney function, bleeding risk, and whether the prescribed dose remains appropriate.
They are not appropriate for every patient. For example, people with mechanical heart valves or moderate-to-severe rheumatic mitral stenosis generally require a different anticoagulation approach.
Warfarin
Warfarin is an older anticoagulant that continues to play an important role in treating certain people with AFib.
It works by interfering with vitamin K-dependent clotting factors. Unlike DOACs, warfarin requires regular blood tests called INR tests to determine whether its anticoagulant effect is within the intended range.
Warfarin can interact with many medications, supplements, and foods. People taking it generally need to keep their dietary vitamin K intake reasonably consistent rather than suddenly making major changes.
Warfarin is particularly important for people with mechanical heart valves and some patients with rheumatic mitral stenosis.
Is aspirin enough to prevent stroke in AFib?
Aspirin is not an adequate substitute for anticoagulant treatment when anticoagulation is recommended to prevent AFib-related stroke.
Aspirin works differently from anticoagulants and is generally less effective for preventing the types of blood clots associated with AFib.
Some people may need aspirin for a separate cardiovascular reason, such as certain forms of coronary artery disease. However, combining aspirin with an anticoagulant can increase bleeding risk and should only be done when there is a specific medical indication.
The American Heart Association's atrial fibrillation guideline summary emphasizes individualized stroke-risk assessment and generally recommends direct oral anticoagulants over warfarin for eligible patients, except those with mechanical heart valves or moderate-to-severe mitral stenosis.
How Do Doctors Choose the Right AFib Medication?
There is no single medicine that works best for every person with AFib. Treatment decisions involve balancing heart rate control, rhythm control, stroke prevention, and medication safety.
Heart symptoms and rhythm pattern
Doctors consider whether AFib occurs in occasional episodes or is more persistent. They also assess symptoms such as palpitations, reduced exercise tolerance, fatigue, and shortness of breath.
If symptoms improve with adequate heart rate control, a rate-control strategy may be appropriate. If symptoms continue, a rhythm-control approach may be considered.
Rhythm control can also be appropriate earlier in the course of AFib for selected patients, rather than only after rate-control medicines have failed.
Heart function and other medical conditions
Heart failure, coronary artery disease, kidney disease, thyroid problems, and other health conditions can influence medication choices.
For example, certain calcium channel blockers may be unsafe in people with significantly reduced heart pumping function. Some antiarrhythmic drugs are unsuitable for patients with particular structural heart problems.
An ECG, echocardiogram, and blood tests may help doctors choose treatment and identify medications that require additional monitoring.
Age, stroke risk, and bleeding risk
Age is an important factor in AFib treatment, particularly when deciding whether anticoagulation is needed.
Doctors often use a structured stroke-risk assessment that considers age, high blood pressure, diabetes, heart failure, previous stroke, and vascular disease. The exact scoring approach can differ between clinical guidelines.
People aged 65 or older may have a higher stroke risk, and risk generally increases further with age. However, anticoagulant treatment is based on the person's overall risk rather than age alone.
Bleeding history, kidney function, other medicines, and personal preferences also influence the decision. Older adults may need particularly careful medication review, but age alone does not automatically rule out anticoagulant treatment.
What Side Effects Should You Watch for With AFib Medicines?
Different AFib medicines have different risks. Knowing their possible effects helps patients recognize changes that deserve medical attention.
Side effects of heart rate medicines
Beta blockers, diltiazem, verapamil, and digoxin may cause an excessively slow heart rate or other unwanted effects in some patients.
Dizziness, unusual weakness, persistent fatigue, or worsening exercise tolerance should be discussed with a healthcare professional, especially after a medication has been started or adjusted.
Side effects of rhythm-control medicines
Antiarrhythmic medicines can occasionally cause new or worsening rhythm disturbances. Some also affect blood pressure, kidney function, or other organs.
Because these risks vary by drug, monitoring may include ECGs, blood tests, or additional examinations.
Bleeding risks with anticoagulants
All anticoagulants increase the likelihood of bleeding. Minor bruising or prolonged bleeding from small cuts can occur, but more significant bleeding requires prompt assessment.
Blood in the urine, black stools, vomiting blood, or bleeding that does not stop are concerning signs. Heavy or uncontrolled bleeding requires emergency medical care.
Sudden facial weakness, difficulty speaking, loss of vision, or weakness on one side of the body may indicate a stroke and require immediate emergency assessment, even if the person is already taking a blood thinner.
Can Atrial Fibrillation Medicines Be Taken Together?
Yes. Some people need more than one medicine because controlling the heartbeat and preventing stroke are separate treatment goals.
For example, a clinician may prescribe a beta blocker to slow the heart rate and an anticoagulant to reduce stroke risk. Others may receive an antiarrhythmic drug alongside medication that controls how quickly electrical signals reach the lower heart chambers.
However, combining medicines that slow the heartbeat can sometimes cause excessive slowing or low blood pressure. Antiarrhythmic medicines may also interact with anticoagulants or other prescriptions.
For this reason, medication combinations should be selected and adjusted by a healthcare professional. Patients should provide an accurate list of prescription medicines, over-the-counter drugs, vitamins, and supplements.
Will You Need AFib Medicine for Life?
Some people require long-term medication, while others may have treatment adjusted as their heart rhythm and overall health change.
A rate-control medicine may continue for years if it helps maintain an acceptable heart rate. An antiarrhythmic medicine may be changed or discontinued if it becomes ineffective, causes side effects, or is no longer needed following another treatment.
Anticoagulant decisions are different. Even when AFib symptoms disappear or a normal rhythm is restored, some people still need stroke-prevention medication because their underlying risk remains elevated.
According to the NHS, AFib treatment can include medicines to control heart rate and rhythm, anticoagulants to reduce clotting risk, and procedures when appropriate. Regular follow-up helps clinicians check whether treatment continues to meet the patient's needs.
Stopping an anticoagulant or heart rhythm medication without medical guidance can increase the risk of complications. Decisions about changing treatment should be based on a review of the patient's current health and medical history.
What Happens if AFib Medicines Do Not Work?
Medication does not always provide enough symptom relief or rhythm control. If AFib continues despite treatment, a cardiologist may reassess the diagnosis, medicine dose, potential interactions, and other conditions contributing to the rhythm problem.
Some people may benefit from electrical cardioversion, which uses a controlled electrical shock to restore a normal rhythm.
Another option is catheter ablation, a procedure that targets areas of heart tissue involved in abnormal electrical signals. In selected patients, ablation may be considered early rather than only after several medications have been tried.
These treatments do not necessarily remove the need for anticoagulation. Stroke prevention remains an independent consideration based on individual risk.
How Can You Take AFib Medicines Safely?
Taking medication consistently and attending follow-up appointments are important parts of AFib management. The following practices can help patients use prescribed treatments safely.
Follow the prescribed schedule. Heart rhythm medicines and anticoagulants should be taken exactly as directed. Missing doses or changing the amount without guidance may reduce treatment effectiveness or increase risks.
Know what to do after a missed dose. Instructions differ between medicines. Patients should follow the guidance supplied for their specific drug rather than automatically doubling the next dose.
Attend monitoring appointments. Some medicines require ECG testing, kidney function tests, electrolyte checks, or INR monitoring.
Check before adding new medicines. Certain pain relievers, antibiotics, supplements, and other medicines can interact with AFib treatments. A pharmacist or prescriber can help assess possible interactions.
Tell healthcare professionals about anticoagulants. Dentists, surgeons, and other clinicians need this information before procedures. Patients should not stop blood thinners for a procedure unless their treating team provides a specific plan.
Report concerning changes. Persistent palpitations, increasing breathlessness, fainting, or new medication side effects deserve medical review. Chest pain, severe breathing difficulty, stroke-like symptoms, or collapse require emergency assistance.
AFib medicines work best when treatment goals are clear and the plan is reviewed as health needs change. Understanding whether each drug controls the heartbeat, maintains its rhythm, or prevents stroke can make conversations with a cardiologist more useful.